JCAVX
Price
$10.04
Change
-$0.09 (-0.89%)
Updated
Nov 13 closing price
Net Assets
1.15B
RLBBX
Price
$38.70
Change
-$0.49 (-1.25%)
Updated
Nov 13 closing price
Net Assets
268.67B
Interact to see
Advertisement

JCAVX vs RLBBX

Header iconJCAVX vs RLBBX Comparison
Open Charts JCAVX vs RLBBXBanner chart's image
JHFunds2 Capital Appreciation Value NAV
Price$10.04
Change-$0.09 (-0.89%)
VolumeN/A
Net Assets1.15B
American Funds American Balanced R2
Price$38.70
Change-$0.49 (-1.25%)
VolumeN/A
Net Assets268.67B
JCAVX vs RLBBX Comparison Chart in %
View a ticker or compare two or three
VS
JCAVX vs. RLBBX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JCAVX is a Buy and RLBBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBBX has more cash in the bank: 269B vs. JCAVX (1.15B). JCAVX pays higher dividends than RLBBX: JCAVX (2.07) vs RLBBX (1.09). JCAVX was incepted earlier than RLBBX: JCAVX (15 years) vs RLBBX (24 years). RLBBX (1.32) is less costly to investors than JCAVX (0.88). JCAVX is a more actively managed with annual turnover of: 74.00 vs. RLBBX (44.00). JCAVX has a lower initial minimum investment than RLBBX: JCAVX (0) vs RLBBX (250). RLBBX annual gain was more profitable for investors over the last year : 9.11 vs. JCAVX (-1.22). RLBBX return over 5 years is better than : 36.96 vs. JCAVX (-13.48).
JCAVXRLBBXJCAVX / RLBBX
Total Expense Ratio0.871.3266%
Annual Report Gross Expense Ratio0.881.3267%
Fund Existence15 years24 years-
Gain YTD12.43115.50080%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.15B269B0%
Annual Yield % from dividends2.071.09190%
Returns for 1 year-1.229.11-13%
Returns for 3 years14.6640.5936%
Returns for 5 years-13.4836.96-36%
Returns for 10 years-0.7870.07-1%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TRDA8.010.31
+4.03%
Entrada Therapeutics
JPM320.414.79
+1.52%
JPMorgan Chase & Co
COUR8.510.09
+1.07%
Coursera
ZK27.74-0.30
-1.07%
ZEEKR Intelligent Technology Holding Ltd
PMEC1.11-0.07
-5.93%
Primech Holdings Ltd